siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin

doi:10.3748/wjg.v18.i31.4127

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4025)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

334

HTML

3056

Figures (1-5)

402

Tables (1-1)

233

Sum=4025

Aug 21, 2012 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 21, 2012; 18(31): 4127-4135
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4127

Full Size Figure Download Figure

Figure 4 Cell viability assay. TE13 cells were treated with cisplatin in a dose-dependent manner for 24 h. Cell viability was determined using the MTT assay, LD50 was found to be 9 μg/mL. Further treatment with cisplatin was carried out at less than the LD50 dose.

Citation: Hasan MR, Chauhan SS, Sharma R, Ralhan R. siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin. World J Gastroenterol 2012; 18(31): 4127-4135
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4127.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4127